The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Educational Lecture

Educational Lecture 2-3E Adverse events of ABL tyrosine kinase inhibitors in chronic myeloid leukemia therapy

Sat. Oct 13, 2018 2:50 PM - 3:20 PM No.3 (Osaka International Convention Center, 12F Conference Hall)

Chair: Arinobu Tojo (Division of Molecular Therapy, The Institute of Medical Science, The University of Tokyo, Japan)

[EL2-3E] Adverse events of ABL tyrosine kinase inhibitors in chronic myeloid leukemia therapy

Tetsuzo Tauchi (Department of Hematology, Tokyo Medical University, Japan)